Masimo (MASI) Long-Term Investments (2019 - 2026)
Masimo's (MASI) quarterly Long-Term Investments came in at $43.3 million in Q2 2026, down 26.98% year-on-year from $59.3 million in Q2 2025, and little changed quarter-over-quarter from $43.1 million in Q1 2026.
Masimo (MASI) Long-Term Investments (2019 - 2026) Analysis & Trends
Masimo's Long-Term Investments history runs 8 years deep, the most recent figure standing at $43.3 million for Q2 2026.
- On a quarterly basis, Long-Term Investments fell 26.98% year-over-year to $43.3 million in Q2 2026; TTM through Apr 2026 was $43.3 million, a 26.98% decrease from a year earlier, with the FY2026 full-year figure at $43.1 million, down 26.58% from the prior year.
- Long-Term Investments was little changed at $43.3 million in Q2 2026 per MASI's latest filing, from $43.1 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $81.9 million in Q2 2023 and bottomed at $43.1 million in Q1 2026.
- The 5-year median for Long-Term Investments is $70.8 million (2023), against an average of $66.3 million.
- Across the five-year window, Long-Term Investments gained 27.63% in 2022 and fell 26.98% in 2026, its largest moves.
- Year by year, Long-Term Investments stood at $73.1 million in 2022, then dropped by 2.33% to $71.4 million in 2023, then declined by 17.79% to $58.7 million in 2024, then retreated by 17.38% to $48.5 million in 2025, then decreased by 10.72% to $43.3 million in 2026.
- Per Business Quant, the three latest MASI Long-Term Investments figures stand at $43.3 million (Q2 2026), $43.1 million (Q1 2026), and $48.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 43.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 43.30 Mn |
| Jan 3, 2026 | 43.10 Mn |
| Sep 27, 2025 | 48.50 Mn |
| Jun 28, 2025 | 53.20 Mn |
| Mar 29, 2025 | 59.30 Mn |
| Dec 28, 2024 | 58.70 Mn |
| Sep 28, 2024 | 64.20 Mn |
| Jun 29, 2024 | 66.50 Mn |
| Mar 30, 2024 | 70.30 Mn |
| Dec 30, 2023 | 71.40 Mn |
| Sep 30, 2023 | 79.90 Mn |
| Jul 1, 2023 | 77.50 Mn |
| Apr 1, 2023 | 81.90 Mn |
| Dec 31, 2022 | 73.10 Mn |
| Oct 1, 2022 | 79.60 Mn |
| Jul 2, 2022 | 75.40 Mn |
| Apr 2, 2022 | 73.92 Mn |
| Jan 1, 2022 | 73.60 Mn |
| Oct 2, 2021 | 66.96 Mn |
| Jul 3, 2021 | 65.20 Mn |